Beatriz Gros
@Bealoquebea
Gastroenterologist #IBD specialist at @hureinasofia @IMIBIC Help others grow their abilities and celebrate life. IBD education at http://ibd-eii.com
🌟Ever found yourself doubting about IBD new drugs doses? or forgetting Thiopurine metabolism details? I've been there too So I thought it could help having "IBD Cheat Sheets" and that is what I did: ibd-eii.com/ibdcheatsheet I hope it helps as much as it helps me 1/2 #IBD
1/ Our new study at IBD Journal linking Isolated Anastomotic Ulcer (IAU) to long-term recurrence post-operatively and microbiome shifts. @MichielBak @poliverasendra @TurpinWilliams @HaimLeiboIBD @guthealthmd @SinaiHealth @AnthonydeBuck @mantaj_brar academic.oup.com/ibdjournal/adv…
Elegant study on isolated anastomotic ulceration ("pure"i2a) shows they also predict higher recurrence risk (and linked with dysbiosis). Bears to reason, as they are rarely seen in non-IBD anastomoses
1/ Our new study at IBD Journal linking Isolated Anastomotic Ulcer (IAU) to long-term recurrence post-operatively and microbiome shifts. @MichielBak @poliverasendra @TurpinWilliams @HaimLeiboIBD @guthealthmd @SinaiHealth @AnthonydeBuck @mantaj_brar academic.oup.com/ibdjournal/adv…
This 👇is an excellent and workable idea in many settings I had the honour to visit this centre last year and saw first hand the tremendous work done by the #IBD counsellor Ajay Bhardwaj who did his role with a smile This #IBD team is one of the best if not the best in India…
1/ 📝 “Developing IBD Counsellors in Low- and Middle-Income Countries: Bridging Gaps in Patient Care” In many low- and middle-income countries, patients with IBD face delayed diagnoses, fragmented care, limited specialist access, and overwhelming stigma.
🧭 How Deep Should We Go to Define a Target in IBD? In the evolving world of #TreatToTarget, we’re no longer stopping at symptom control. The layers of remission are getting deeper. But… how deep is deep enough? What’s clinically meaningful—and what’s overkill? 💬 What’s your…
Fisiología hepática 🤩 #LiverTwitter 📸: Mai Doodles
Pleased to share our latest article in @UEGJournal Consensus on upper GI endoscopy KPIs and minimum standards to reduce Post Endoscopy Upper Gastrointestinal Cancer rate @GastroMJB @NJEMCP @abdullahaabbasi @SyedGerdezi @drkeithsiau @PEUGIC_RCA onlinelibrary.wiley.com/doi/10.1002/ue…
📢 Just published! 📝 Our review on biologic💉 therapy trends in IBD in 🇸🇦 is now out in the Saudi Journal of Gastroenterology! 🔬 Real-world use 💸 Cost insights 📈 Utilization patterns 📌 Need for a national IBD registry 👉 journals.lww.com/sjga/fulltext/… @SGA_KSA
Un millón de gracias Joaquín!!!
🔍 ¿Usas ecografía intestinal en EII? He creado una herramienta interactiva gratuita para calcular 6 índices ecográficos validados en Crohn y colitis ulcerosa. 💻 En segundos, obtienes resultados claros, con interpretación automática y citando las publicaciones originales. 🧵…
🔁 Repost from @FrontGastro_BMJ ⚠️ 1 in 5 IBS patients may have an undiagnosed eating disorder That’s double the rate seen in IBD or Coeliac disease. 🧠 Younger age + psychiatric comorbidity = highest risk ✅ Use tools like SCOFF to screen early and support better outcomes 📖…
🍽️ Eating Disorders & GI Conditions: What’s the link? 🤔 IBS patients have a higher risk of eating disorders (18%) compared to those with Coeliac Disease (CeD) (9.4%) and Inflammatory Bowel Disease (IBD) (11.5%). Younger patients and those with psychiatric conditions are more…
No me da demasiada pena tener razón desde antiguo en este asunto 👇👇👇👇👇👇👇👇👇
Linked Comment - Unravelling the power of nocebo in symptom response to food challenge in irritable bowel syndrome thelancet.com/journals/langa… #GITwitter #MedTwitter
In the UK and USA, over 50% of daily calories consumed comes from ultra processed foods which can be linked with obesity via the following mechanisms 👇 What other harms are associated with ultra processed foods? 📸: nature.com/articles/s4157…
Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors starting in childhood, including two new risks—high cholesterol and vision loss, suggests report from the Lancet Commission on dementia. On #WorldBrainDay, explore the report ➡️…
New research - Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial thelancet.com/journals/langa… #GITwitter #MedTwitter #IBD
New online! Rethinking gastric cancer prevention through an immigrant health lens bit.ly/4kT5DfH
Nigeria, like much of sub-Saharan Africa, remains underrepresented in IBD research. Published data are scarce, mostly limited to case reports and small series. This study may seem minor to some, but this morning, it reminded me why our work matters and why we need to keep an eye…
It makes me happy to see that this has been proven For people who train and stop for whatever reason is good news and for those who never had is good news because you need to start training sooner rather than later
Does our body have "muscle memory" for endurance adaptations? A fascinating study in the Journal of Applied Physiology explored this concept Researchers examined 20 young adults who underwent an eight-week high-intensity interval training (HIIT) program on stationary bikes,…
#GUTimages from the #GUTRecentAdvancesInBasicScience paper by Gudiño et al entitled "Single-cell omics in inflammatory bowel disease: recent insights and future clinical applications" via bit.ly/40kN0ds #IBD #SingleCellOmics
New @TheLancet - Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3) thelancet.com/journals/lance… #GITwitter #MedTwitter
Very cool pictorial. To add: Both Risa and Miri have Fc LALA mutation to reduce effector ADCC/CDC potential. In contrast, Gus is wild type Ab (unmutated, hence binds CD64=FcRI), but still given/4w or/8w. Whether wild type will yield ⬆️AE or better efficacy remains to be seen.
🎯 Extending the Half-Life of mAbs: Why It Matters in IBD In Crohn’s disease and ulcerative colitis, therapeutic monoclonal antibodies often require frequent dosing—which can burden patients and strain healthcare systems. 🧬 Enter Fc engineering: By tweaking the Fc region of…
Finally - much needed guidance on GI manifestations in hypermobile Ehlers-Danlos Syndrome, covering MCAS and POTS via @AmerGastroAssn 🆕🔢 1️⃣ The guideline 📄 2️⃣ Beighton score for hypermobility🫸 3️⃣ MCAS diagnosis 🩺 4️⃣ Management 💊 📸: sciencedirect.com/science/articl…